Literature DB >> 32126554

Elevated Serum Tryptase in Non-Anaphylaxis Cases: A Concise Review.

Adrian Y S Lee1,2.   

Abstract

One of the most important blood tests in the field of allergy, mast cell tryptase has numerous diagnostic uses, particularly for anaphylactic reactions and for the diagnosis of mastocytosis. However, there are numerous other non-anaphylactic conditions where clinicians may see elevated serum tryptase (hypertryptasemia) and the practicing clinician ought to be aware of these important differential diagnoses. Such conditions include systemic mastocytosis, hematological malignancies, and chronic kidney disease. This article provides a comprehensive, updated summary on the variety of non-anaphylactic conditions where hypertryptasemia may be seen.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Allergy; Anaphylaxis; Diagnosis; Mast cells; Tryptase

Year:  2020        PMID: 32126554     DOI: 10.1159/000506199

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  5 in total

1.  Systematic comparisons of various markers for mast cell activation in RBL-2H3 cells.

Authors:  Chuda Rujitharanawong; Sunisa Yoodee; Kanyarat Sueksakit; Paleerath Peerapen; Papapit Tuchinda; Kanokvalai Kulthanan; Visith Thongboonkerd
Journal:  Cell Tissue Res       Date:  2022-09-20       Impact factor: 4.051

2.  Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients.

Authors:  Giulia Carosi; Gregorio Guabello; Matteo Longhi; Federica Grifoni; Elena Passeri; Sabrina Corbetta
Journal:  Mediators Inflamm       Date:  2020-10-20       Impact factor: 4.711

3.  CoronaVac/Sinovac COVID-19 Vaccine-Related Hypersensitivity Reactions and Second-Dose Vaccine Administration: Tertiary Allergy Center Experience.

Authors:  Reyhan Gumusburun; Ceyda Tunakan Dalgıc; Emine Nihal Mete Gokmen; Aytul Zerrin Sin
Journal:  Int Arch Allergy Immunol       Date:  2022-04-22       Impact factor: 3.767

Review 4.  A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination.

Authors:  Lii Jye Tan; Cai Ping Koh; Shau Kong Lai; Woon Cheng Poh; Mohammad Shafie Othman; Huzlinda Hussin
Journal:  Forensic Sci Int       Date:  2022-09-20       Impact factor: 2.676

5.  Dose-dependent inactivation of airway tryptase with a novel dissociating anti-tryptase antibody (MTPS9579A) in healthy participants: A randomized trial.

Authors:  Sharon M Rymut; Siddharth Sukumaran; Gizette Sperinde; Meire Bremer; Joshua Galanter; Kenta Yoshida; Jordan Smith; Prajna Banerjee; Viyia Sverkos; Fang Cai; Verena Steffen; Lindsay M Henderson; Horace Rhee; Paula N Belloni; Joseph H Lin; Tracy L Staton
Journal:  Clin Transl Sci       Date:  2021-09-30       Impact factor: 4.689

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.